Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,192Revenue $M443Net Margin (%)55.4Z-Score4.0
Enterprise Value $M1,482EPS $1.7Operating Margin %91.2F-Score3
P/E(ttm))4.5Cash Flow Per Share $1.5Pre-tax Margin (%)87.3Higher ROA y-yN
Price/Book4.110-y EBITDA Growth Rate %0Quick Ratio0.8Cash flow > EarningsN
Price/Sales2.55-y EBITDA Growth Rate %20.0Current Ratio0.8Lower Leverage y-yY
Price/Cash Flow5.0y-y EBITDA Growth Rate %8.2ROA % (ttm)44.9Higher Current Ratio y-yN
Dividend Yield %8.1Insider Buy (3m)0ROE % (ttm)213Less Shares Outstanding y-yN
Payout Ratio %36.0Shares Outstanding M161ROI % (ttm)162Gross Margin Increase y-yN

Gurus Latest Trades with PDLI

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PDLIJohn Hussman 2014-06-30 Sold Out -0.68%$8 - $9.85
($8.9)
$ 7.49-16%Sold Out0
PDLIJoel Greenblatt 2014-06-30 Reduce-0.11%$8 - $9.85
($8.9)
$ 7.49-16%Reduce -52.58%789,804
PDLIJoel Greenblatt 2014-03-31 Reduce-0.34%$7.46 - $9.14
($8.57)
$ 7.49-13%Reduce -50.19%1,665,543
PDLIJohn Hussman 2013-12-31 Reduce-0.49%$7.59 - $10.1
($8.43)
$ 7.49-11%Reduce -50.99%1,087,000
PDLIJoel Greenblatt 2013-09-30 Add0.15%$7.72 - $8.44
($8.04)
$ 7.49-7%Add 24.84%2,890,564
PDLIJohn Hussman 2013-09-30 Reduce-0.21%$7.72 - $8.44
($8.04)
$ 7.49-7%Reduce -21.04%2,218,000
PDLIJoel Greenblatt 2013-03-31 Add0.15%$6.65 - $7.53
($7.08)
$ 7.496%Add 23.5%2,135,460
PDLIJoel Greenblatt 2012-12-31 Add0.59%$7.09 - $8.37
($7.75)
$ 7.49-3%Add 561.89%1,729,133
PDLIJohn Hussman 2012-12-31 Add0.09%$7.09 - $8.37
($7.75)
$ 7.49-3%Add 20.19%3,012,000
PDLIJohn Hussman 2012-09-30 Add0.29%$6.59 - $7.73
($7.11)
$ 7.495%Add 176.91%2,506,000
PDLIJoel Greenblatt 2012-03-31 Add0.04%$6.02 - $6.58
($5.93)
$ 7.4926%Add 33.54%270,346
PDLISeth Klarman 2012-03-31 Sold Out -1.5%$6.02 - $6.58
($5.93)
$ 7.4926%Sold Out0
PDLIJoel Greenblatt 2011-12-31 Add0.04%$5.35 - $6.4
($5.97)
$ 7.4926%Add 31.29%202,444
PDLISeth Klarman 2011-12-31 Reduce-1.4%$5.35 - $6.4
($5.97)
$ 7.4926%Reduce -48.84%8,000,000
PDLIGeorge Soros 2011-12-31 Sold Out -0.001%$5.35 - $6.4
($5.97)
$ 7.4926%Sold Out0
PDLISeth Klarman 2011-09-30 Add1.17%$5.47 - $6.39
($5.91)
$ 7.4927%Add 68.81%15,636,000
PDLIJohn Hussman 2011-09-30 Buy 0.08%$5.47 - $6.39
($5.91)
$ 7.4927%New holding, 905000 sh.905,000
PDLIJoel Greenblatt 2011-09-30 Add0.04%$5.47 - $6.39
($5.91)
$ 7.4927%Add 41.81%154,201
PDLIGeorge Soros 2011-09-30 Buy $5.47 - $6.39
($5.91)
$ 7.4927%New holding, 10000 sh.10,000
PDLIGeorge Soros 2011-06-30 Sold Out $5.74 - $6.64
($6.23)
$ 7.4920%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PDLI is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PDLI Jean-Marie Eveillard 2014-06-302,80000
PDLI Joel Greenblatt 2014-06-30789,8040.490.1-52.58%
PDLI John Hussman 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


PDLI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lindell Jody SDirector 2011-03-15Buy374$5.3341.28view
LARSON CHRISTINE RVice President and CFO 2010-05-14Buy5,000$5.7131.87view
LARSON CHRISTINE RVice President and CFO 2010-04-30Buy10,000$6.1821.84view
KLEIN JOSEPH IIIDirector 2009-11-04Sell24,000$8.33-9.6view
Lindell Jody SDirector 2009-06-15Buy3,000$7.76-2.96view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.382.03view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.382.03view
KLEIN JOSEPH IIIDirector 2008-05-20Buy500$9.5-20.74view
KLEIN JOSEPH IIIDirector 2008-05-06Buy500$9.6-21.56view
KLEIN JOSEPH IIIDirector 2008-04-21Buy500$13.87-45.71view

Press Releases about PDLI :

Quarterly/Annual Reports about PDLI:

News about PDLI:

Articles On GuruFocus.com
Hot Picks with High Yields Jul 23 2013 
My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio Jun 03 2013 
comment on PDLI May 12 2013 
My 4 Favorites From The 20 Cheapest Healthcare Dividend Stock List May 02 2013 
FV 22 MSN 10 Apr 19 2013 
68 Top-Yielding Stocks with Ex-Dividend Date in March 2013 Feb 27 2013 
20 Best Yielding Healthcare Growth Stocks and Which to Buy Feb 02 2013 
comment on PDLI Nov 13 2012 
Seth Klarman’s Investment Framework Sep 15 2012 
A Look at Two Undervalued Small-Cap Health Care Stocks Aug 09 2012 

More From Other Websites
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against PDL BioPharma... Sep 30 2014
Law Offices of Marc S. Henzel Announces Securities Class Action Periods Sep 30 2014
PDL BIOPHARMA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds... Sep 29 2014
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From... Sep 29 2014
Lifshitz & Miller Law Firm Announces Investigation of CommVault Systems, Inc., Dresser-Rand Group... Sep 24 2014
PDL BioPharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate... Sep 24 2014
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against PDL BioPharma... Sep 23 2014
Robbins Arroyo LLP: PDL BioPharma, Inc. (PDLI) Accused of Violating Federal Law and Causing Investor... Sep 23 2014
PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 23 2014
PDL BioPharma Responds to Class Action Lawsuit Sep 23 2014
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Sep 22 2014
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in PDL... Sep 22 2014
EQUITY ALERT: The Rosen Law Firm Announces Filing of Securities Class Action Against PDL BioPharma,... Sep 21 2014
Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. Sep 19 2014
Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against PDL BioPharma,... Sep 19 2014
INVESTOR ALERT: Investigation on Behalf of PDL BioPharma, Inc. Shareholders Announced by Glancy... Sep 19 2014
PDL BIOPHARMA -- Law Firm Announces Class Action Lawsuit Brought on Behalf of Shareholders to... Sep 19 2014
Pomerantz Law Firm Announces the Filing of a Class Action Against PDL BioPharma, Inc. and Certain... Sep 18 2014
PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 18 2014
PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors Sep 17 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK